腹腔镜门静脉流域荧光导航解剖性肝切除在肝细胞癌中的安全性与疗效
匹配后LPTAR组切缘更宽(13.00 cm vs. 11.00 cm,P=0.023)、出血更少(200 ml vs. 320 ml,P=0.010)、术后并发症更少(33.90% vs. 57.62%,P=0.016),且1、3、5年无复发生存率显著更高(P=0.002)。结论认为精准术前规划和标准化LPTAR技术可延长HCC患者RFS、提高手术安全性并减轻手术应激。
要点
- LPTAR组切缘更宽、出血更少、术后并发症更少。
- LPTAR组1、3、5年无复发生存率显著高于CAR组(P=0.002)。
- 精准术前规划与标准化LPTAR技术可延长RFS并提高安全性。
核心结论
- 精准术前规划和标准化LPTAR技术可延长HCC患者无复发生存期、提高手术安全性并减轻手术应激。
主要发现
- PSM后每组59例,LPTAR组切缘宽度为13.00 cm、CAR组为11.00 cm(P=0.023)。
- LPTAR组出血量为200 ml、CAR组为320 ml(P=0.010)。
- LPTAR组术后并发症发生率为33.90%、CAR组为57.62%(P=0.016)。
- LPTAR组1、3、5年无复发生存率显著高于CAR组(P=0.002)。
临床怎么用
- 在HCC腹腔镜肝切除中,可考虑采用LPTAR以争取更宽切缘、减少出血和术后并发症,并可能改善无复发生存。
局限性
- 本研究为回顾性队列研究,证据级别受设计类型限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The clinical effectiveness of classic anatomical resection (CAR) of the liver for hepatocellular carcinoma (HCC) has been controversial. Laparoscopic Portal Territory fluorescence navigation-guided anatomical liver resection (LPTAR) has been increasingly applied in clinical practice. However, evidence on the safety and efficacy of LPTAR is lacking. METHODS: A retrospective cohort study of patients who underwent laparoscopic hepatectomy from December 2018 to December 2022 was conducted. Propensity score matching (PSM) was employed to match patients who underwent LPTAR with patients who underwent CAR. Differences in recurrence-free survival (RFS), overall survival (OS), and perioperative data were evaluated between the LPTAR and CAR groups. Cox regression models were used for univariate and multivariate analyses, as well as subgroup analyses. RESULTS: Of the 234 patients included in this study, 70 underwent LRTAR, and 164 underwent CAR. After 1:1 PSM, each group contained 59 patients, and perioperative parameters were better in the LPTAR group. Specifically, the LPTAR group had wider resection margins (13.00 cm vs. 11.00 cm, P = 0.023), less blood loss (200 ml vs. 320 ml, P = 0.010), and fewer postoperative complications (33.90% vs. 57.62%, P = 0.016) than did the CAR group. The RFS rates of patients with HCC was also increased by LPTAR. The 1-, 3-, and 5-year RFS rates of the LPTAR group were significantly higher than those of the CAR group (P = 0.002). CONCLUSION: Accurate preoperative planning and standardized LPTAR technical criteria prolonged RFS in HCC patients, improved the safety of surgery, and reduced surgical stress. TRAIL REGISTRATION: The study has been prospective registered at Chinese Clinical Trial Registry (https://www.chictr.org.cn/, ChiCTR2400087661).
引用
- Wang AZ, Zhou R, Chen J, et al. Safety and efficacy of laparoscopic portal territory fluorescence navigation-guided anatomical liver resection in hepatocellular carcinoma patients. Surg Endosc. 2025. PMID: 40050494. doi:10.1007/s00464-025-11632-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。